Psycho‐Oncology最新文献

{"title":"Systematic Review of Pain Assessment Measures Used in Pediatric Acute Lymphoblastic Leukemia.","authors":"Kimberly L Klages, Courtney A Gibson, Kimberly A Barnett, Laura E Schwartz, Chloe A Hicks, Robin E Norris, Susmita Kashikar-Zuck, Ahna L H Pai","doi":"10.1002/pon.70063","DOIUrl":"https://doi.org/10.1002/pon.70063","url":null,"abstract":"<p><strong>Background: </strong>Pain is a prevalent, frequent, and often persistent symptom among children with acute lymphoblastic leukemia (ALL). Despite its high prevalence, pain has remained understudied, and no evidence-based recommendations exist for how best to assess and treat pain in this population. Without proper assessment, clinical efforts to improve pain management in pediatric ALL will be ineffective.</p><p><strong>Aims: </strong>Therefore, the purpose of this systematic review is to describe and identify gaps in measurement approaches that have been used to assess pain in pediatric ALL, evaluate the psychometric properties of available pediatric pain measures, and provide recommendations for clinical research and practice.</p><p><strong>Methods: </strong>Literature searches were performed following Cochrane and PRISMA guidelines for systematic reviews. Domains of pain assessed, measures used to assess pain, measure format, respondent, and timing of pain assessment were extracted from studies that met inclusion criteria. The psychometric properties of included measures were then evaluated. A total of 238 full-text articles were screened and 123 met inclusion criteria.</p><p><strong>Results: </strong>Most studies assessed pain using generic health-related quality of life instruments rather than pain-specific measures. A total of 39 measures were used across the 123 included studies, and the psychometric properties of the measures varied considerably.</p><p><strong>Conclusions: </strong>Recommendations include a selection of well-validated pain assessment measures that are currently available and can be used to facilitate best practices in ALL pain assessment. Clinicians and investigators are encouraged to utilize a multidimensional pain assessment approach to inform and enhance pain care in pediatric ALL.</p>","PeriodicalId":20779,"journal":{"name":"Psycho‐Oncology","volume":"34 1","pages":"e70063"},"PeriodicalIF":3.3,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142922671","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Investigation of the Relationship Between Intolerance of Uncertainty, Metacognitions, Maladaptive Coping, and Fear of Cancer Recurrence via Moderated Mediation Model.","authors":"Mübeccel Kübra Babadostu, Aslı Eyrenci","doi":"10.1002/pon.70076","DOIUrl":"https://doi.org/10.1002/pon.70076","url":null,"abstract":"<p><strong>Objective: </strong>In recent years, many studies have investigated the triggers, perpetuating factors, and outcomes of Fear of Cancer Recurrence (FCR), highlighting its complexity with multiple dimensions that encompass both antecedents and consequences. In this sense, the cognitive approach to FCR has explored variables such as metacognition, maladaptive coping strategies, and intolerance of uncertainty (IU). On the other hand, the findings of a restricted number of studies investigating the relationship between FCR and stated variables appear to be inconsistent. The objective of this study was thus to examine the relationship that existed among these variables in breast cancer survivors by moderated mediation model.</p><p><strong>Methods: </strong>In this cross-sectional study, 130 breast cancer survivors completed the Fear of Cancer Recurrence Inventory (FCRI), the Intolerance of Uncertainty Scale Short Form (IUS-12), Metacognitions Questionnaire-30 (MCQ-30), and Brief COPE Scale (BCS) Short Form. The mediated moderation analysis was conducted using Process Macro.</p><p><strong>Results: </strong>There was a significant positive correlation found between FCR and IU (r = 0.87, p < 0.001), and between FCR and negative metacognitions (r = 0.72, p < 0.001). A weak to moderate positive correlation was identified between IU and maladaptive coping strategies (r = 0.19, p < 0.05), and between negative metacognitions and maladaptive coping strategies (r = 0.31, p < 0.001). The relationship between FCR and maladaptive coping strategies was nonsignificant (r = 0.16, p > 0.05). As a result of hierarchical regression analysis, controlling for demographic and clinical variables, IU, positive metacognitions, and negative metacognitions significantly explained 45%, 2%, and 1% of the variance in FCR, respectively.</p><p><strong>Conclusion: </strong>The results of the current study contribute to the literature in terms of supporting the views that cognitive models of worrying could be used to understand the FCR mechanism and address the IU been which has limitedly studied in the FCR literature. The current study's findings have also contributed to the clinical field by highlighting the importance of incorporating breast cancer survivors' metacognitions and IU in FCR intervention programs.</p>","PeriodicalId":20779,"journal":{"name":"Psycho‐Oncology","volume":"34 1","pages":"e70076"},"PeriodicalIF":3.3,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142971696","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Breast Cancer Patients' Experiences of Coping With Financial Toxicity: A Systematic Review and Qualitative Meta-Synthesis.","authors":"Liu Jiahui, Li Xingfeng, Wang Lijie, Li Xuying, Li Jinhua, Fang Yunxia, Chen Jiejun","doi":"10.1002/pon.70075","DOIUrl":"10.1002/pon.70075","url":null,"abstract":"<p><strong>Objective: </strong>Breast cancer patients often face a significant financial burden, leading to financial toxicity due to the necessity for long-term care, costly treatment, and follow-up measures. The purpose of this study is to systematically review the available qualitative evidence on how breast cancer patients cope with financial toxicity and their unmet need to promote the implementation of effective intervention strategies.</p><p><strong>Methods: </strong>PubMed, Web of Science, PsycINFO, CINAHL, EMBASE, Scopus, CNKI, Wan Fang Data, and VIP databases were systematically searched for literature related to the study topic. This study was conducted according to the PRIMSA guidelines. Thematic synthesis methods were used to analyze the data and construct themes. The review was pre-registered on PROSPERO (CRD42024502030).</p><p><strong>Results: </strong>The search yielded 1164 results; 23 articles met the inclusion criteria and reported on a total of 1098 breast cancer patients. The thematic analysis identified three themes and 15 sub-themes: coping emotions (shrouded in negative emotions and adopting a positive attitude); coping behaviors (increasing income sources, adjusting personal or family finances, seeking and accepting support, coping independently, avoidance, constrained decision, financial planning, and proactive negotiation); and coping needs (health insurance policy support, medical institutional support, non-medical institutional resources support, financial information needs, financial management needs).</p><p><strong>Conclusion: </strong>Breast cancer patients exhibit a variety of emotional reactions and coping behaviors with financial toxicity alongside several unmet needs. This indicates the necessity of maintaining focus on financial toxicity in breast cancer patients and the implementation of appropriate management strategies to address their needs while optimizing the detection and mitigation of expenditures that jeopardize their health and quality of life.</p>","PeriodicalId":20779,"journal":{"name":"Psycho‐Oncology","volume":"34 1","pages":"e70075"},"PeriodicalIF":3.3,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11737291/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143010453","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Understanding Cancer Treatment Decision Making Among Cancer Survivors: Weighing Cancer Recurrence Versus Cardiotoxicity.","authors":"Brennan P Streck, Jacqueline B Vo, Carolyn Brandt, William M P Klein, Paul Han, Rebecca A Ferrer, Arielle S Gillman","doi":"10.1002/pon.70061","DOIUrl":"10.1002/pon.70061","url":null,"abstract":"<p><strong>Background: </strong>Nearly 20% of US cancer survivors develop cardiovascular disease (CVD) from cardiotoxic cancer treatments. Patients and providers may consider alternative treatments to lower cardiotoxicity risk, but these may be less effective at preventing relapse/recurrence, presenting a difficult tradeoff.</p><p><strong>Aims: </strong>This study explored survivors' cancer treatment decision-making when weighing this tradeoff.</p><p><strong>Methods: </strong>Using adjusted multivariable logistic regression, we examined 443 US survivors' risk perceptions (deliberative, affective, and intuitive) about cancer and CVD and associations of these with their selection between two hypothetical cancer treatments: Treatment A: 5% chance of cancer recurrence and 10% chance of CVD; Treatment B: 10% chance of recurrence and 5% chance of CVD. We explored the effects of delay discounting by randomizing to a condition describing cancer recurrence/CVD as either immediate or delayed.</p><p><strong>Results: </strong>More survivors (Mage = 48, range = 18-93; M = 10.8 years post-diagnosis) selected Treatment A than Treatment B (72% v. 28%). Timing of onset was not associated with treatment selection. Greater affective risk perception (worry) about cancer was associated with increased odds of choosing Treatment A, whereas greater CVD worry was associated with decreased odds (OR-cancer = 1.33, p = 0.006; OR-CVD = 0.72, p = 0.007). Neither deliberative nor experiential risk perceptions were associated with treatment choice.</p><p><strong>Conclusions: </strong>Survivors were more likely to select the treatment that minimized recurrence rather than CVD-regardless of the timing of onset. Treatment decision was linked to both cancer- and CVD-related worry but not deliberative or experiential risk perceptions. During treatment discussions, clinicians should open conversations about the risks of treatment-associated cardiotoxicity, the probabilities, and patients' relative worries about cancer and cardiotoxicity.</p>","PeriodicalId":20779,"journal":{"name":"Psycho‐Oncology","volume":"34 1","pages":"e70061"},"PeriodicalIF":3.3,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11739822/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143010583","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Abstracts from the American Psychosocial Oncology Society 22nd Annual Conference, 5-7 March 2025.","authors":"","doi":"10.1002/pon.70089","DOIUrl":"https://doi.org/10.1002/pon.70089","url":null,"abstract":"","PeriodicalId":20779,"journal":{"name":"Psycho‐Oncology","volume":"34 Suppl 1 ","pages":"e70089"},"PeriodicalIF":3.3,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143557836","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Socio-Economic Inequalities in Beliefs About Cancer and its Causes: Evidence From two Population Surveys.","authors":"Sergio Iván Galicia Pacheco, Andrés Catena, María José Sánchez, Maria Del Mar Rueda, Lucas Aljarilla Sánchez, Laura Costas, Dunia Garrido, Rocio Garcia-Retamero, Carolina Espina, Miguel Rodríguez-Barranco, Dafina Petrova","doi":"10.1002/pon.70035","DOIUrl":"10.1002/pon.70035","url":null,"abstract":"<p><strong>Objective: </strong>People's beliefs about cancer can affect the actions they take to prevent and detect the disease. We investigated socio-economic inequalities in beliefs about cancer and its causes in the general population.</p><p><strong>Methods: </strong>We analyzed data from the representative probabilistic Spanish Oncobarometer survey (N = 4769, 2020) and the non-probabilistic weight-corrected Spanish Cancer Awareness Survey (N = 1029, 2022). Beliefs about cancer, recognition of cancer symptoms, and recognition of risk factors were measured with the Awareness and Beliefs about Cancer questionnaire. Endorsement of mythical causes was measured with the CAM-Mythical Causes questionnaire. The effects of socio-economic status (SES) were investigated in multiple regression analyses adjusted for age, sex, and personal and family cancer history.</p><p><strong>Results: </strong>Individuals with lower SES were more likely to endorse pessimistic beliefs (e.g., \"cancer is a death sentence\"), and less likely to endorse optimistic beliefs about cancer (e.g., \"people with cancer continue with normal activities\"). Individuals with lower SES also recognized fewer cancer symptoms and risk factors and endorsed more mythical causes of cancer. The gap in knowledge regarding cancer causes was wider among people with low SES, who were more likely to endorse several mythical causes than some established risk factors included in cancer prevention recommendations.</p><p><strong>Conclusions: </strong>Socio-economic inequalities in beliefs about cancer are robust and multidimensional and indicate worse preparedness to act against the disease among lower socio-economic groups. Differences in beliefs about disease outcomes and causes are likely one of the multiple contributors to cancer disparities and should be targeted and monitored in prevention efforts.</p>","PeriodicalId":20779,"journal":{"name":"Psycho‐Oncology","volume":"33 12","pages":"e70035"},"PeriodicalIF":3.3,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11613968/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142771607","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Hypnosis for Antineoplastic-Related Taste Disturbance in a Patient With Metastatic Breast Cancer.","authors":"Corey Saperia, Nathan Tran, Nahom Zewde, David Spiegel","doi":"10.1002/pon.70052","DOIUrl":"https://doi.org/10.1002/pon.70052","url":null,"abstract":"<p><p>Taste disturbances are prominent side effects of antineoplastic medications and contribute to morbidity and quality-of-life impairment. Few treatment options are available for antineoplastic-related taste disorders. Hypnosis has been found to be effective for a variety of symptoms in the cancer setting, including insomnia, pain, mood disorders and anxiety. Numerous somatosensory perceptual changes have been observed with hypnosis, including perception of tactile stimuli and color. Here, we report a case of a 74-year-old woman with recurrent metastatic breast cancer presenting with an 18-month history of antineoplastic-related hypogeusia. She was treated with hypnosis and reported resolution of taste symptoms after 10 days of daily practice. Her improvement seems to be related to hypnotic changes in somatosensory perception, which may be associated with functional alterations in salience, executive control and default mode networks during hypnosis. Further investigation of hypnosis for antineoplastic-related taste disturbances is indicated.</p>","PeriodicalId":20779,"journal":{"name":"Psycho‐Oncology","volume":"33 12","pages":"e70052"},"PeriodicalIF":3.3,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142855176","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The Renewing Intimacy and SExuality Intervention for Female Cancer Survivors: A Feasibility Study.","authors":"Irene Teo, Yee Pin Tan, Alyssa Goh, Fang Ting Pan, Tira J Tan, Semra Ozdemir, Yin Bun Cheung, Isha Chaudhry, Nurul Syaza Razali, Komal G Tewani","doi":"10.1002/pon.70037","DOIUrl":"https://doi.org/10.1002/pon.70037","url":null,"abstract":"<p><strong>Purpose: </strong>This study examined the feasibility and acceptability of a three-session, psychological-based intervention to improve intimacy and sexuality outcomes among women with breast and gynaecologic cancer in Singapore.</p><p><strong>Method: </strong>Patients from outpatient oncology clinics completed screeners for marital and sexual distress. Those who endorsed either marital or sexual distress were invited into the study, and were randomized to receive the intervention immediately or be waitlisted. Intervention feasibility (i.e., reach, adherence) and acceptability (i.e., satisfaction, cultural sensitivity, willingness to pay) and marital, sexual, and body image outcome changes were examined.</p><p><strong>Results: </strong>1101 patients completed the screener; 24% of patients with breast or gynaecologic cancer reported marital or sexual distress. Forty-six patients who were eligible participated in the study. The majority (88%) of participants who started the intervention completed all 3 sessions. All (100%) participants who completed the intervention reported satisfaction and the majority (97%) reported they would recommend the intervention to a friend. The majority of participants found the intervention to be culturally sensitive (93%) and reported being willing to pay either out of pocket or through their national medical MediSave account (76%). Outcome changes were in expected directions with small effect sizes (0.24-0.42). Several themes emerged from open-ended feedback on what participants found useful and how the intervention can be improved.</p><p><strong>Conclusions: </strong>Approximately one quarter of breast or gynaecologic cancer patient who are partnered in Singapore reported marital or sexual distress. Despite the low reach, we found good adherence and high acceptability of the psychological-based intervention. Our findings suggest there is room to improve awareness and delivery of sexuality-related care in an oncology setting.</p><p><strong>Trial registration: </strong>Number and date: NCT03420547, April 10, 2018.</p>","PeriodicalId":20779,"journal":{"name":"Psycho‐Oncology","volume":"33 12","pages":"e70037"},"PeriodicalIF":3.3,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142786793","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The Worries About Recurrence or Progression Scale in Cancer (WARPS-C): A Valid and Reliable Measure to Screen for Fear of Cancer Recurrence.","authors":"Maddison Smith, Louise Sharpe, Natalie Winiarski, Joanne Shaw","doi":"10.1002/pon.70055","DOIUrl":"https://doi.org/10.1002/pon.70055","url":null,"abstract":"<p><strong>Objective: </strong>The Worries About Recurrence or Progression Scale (WARPS) was recently validated in four common chronic illnesses other than cancer, after a rigorous development process based on the COSMIN criteria. Available measures of fear of progression or fear of cancer recurrence (FCR) have been criticised for not meeting all COSMIN criteria. Therefore, this study aimed to explore the psychometric properties of the WARPS in a cancer sample to assess its applicability to measure FCR.</p><p><strong>Methods: </strong>We recruited 346 participants living with or beyond cancer for an online survey. The psychometric properties of the WARPS were examined using a confirmatory factor analysis. Convergent validity was assessed against the current gold standard questionnaires and constructs related to FCR. Some participants completed a follow-up survey 2 weeks later, to assess the test-retest reliability. Finally, a Receiver Operating Characteristics analysis was conducted to determine clinical cut-offs for the WARPS.</p><p><strong>Results: </strong>Confirmatory factor analysis confirmed that the WARPS has one underlying factor, fear of recurrence or progression (FRP), with adequate model fit. The WARPS demonstrated excellent internal consistency, test-retest reliability and showed convergent validity. ROC analysis revealed a cut-off of 54 for moderate, and 65 for severe FCR on the WARPS.</p><p><strong>Conclusions: </strong>The WARPS demonstrated good psychometric properties in a cancer sample. It has the capacity to be used as a screening tool to identify clinical levels of FCR. The WARPS was developed consistent with the COSMIN criteria and overcomes some of the limitations of existing measures.</p>","PeriodicalId":20779,"journal":{"name":"Psycho‐Oncology","volume":"33 12","pages":"e70055"},"PeriodicalIF":3.3,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142872798","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Intervention-Related Changes in Coping Ability Drives Improvements in Mood and Quality of Life for Patients Taking Adjuvant Endocrine Therapy.","authors":"Leah E Walsh, Laura Dunderdale, Nora Horick, Jennifer S Temel, Joseph A Greer, Jamie M Jacobs","doi":"10.1002/pon.70049","DOIUrl":"10.1002/pon.70049","url":null,"abstract":"<p><strong>Objective: </strong>A recent randomized trial of a group psychosocial telehealth intervention (STRIDE) improved anxiety, depression, quality of life (QOL), symptom distress, coping, and self-efficacy to manage symptoms related to taking adjuvant endocrine therapy (AET) in women with non-metastatic hormone receptor-positive breast cancer. This study examined whether changes in coping and self-efficacy mediated intervention effects on anxiety, depression, QOL, and symptom distress.</p><p><strong>Method: </strong>Women (N = 100) were recruited between 10/2019-06/2021 from Massachusetts General Hospital and were randomized to STRIDE or to the medication monitoring control group. Participants completed self-report measures of anxiety and depression (Hospital Anxiety and Depression Scale), QOL (Functional Assessment of Cancer Therapy-Breast Cancer scale), symptom distress (Breast Cancer Prevention Trial Symptom Scale), coping (Measure of Current Status-Part A), and self-efficacy (Self Efficacy for Managing AET Symptoms) at baseline and 24-week follow-up. Mediated regression models tested whether changes in coping ability and self-efficacy mediated the intervention effects on anxiety, depression, QOL, and symptom distress, controlling for key variables.</p><p><strong>Results: </strong>Improvements in coping across the 24-week study period mediated the effect of STRIDE on anxiety symptoms (indirect effect, B = -0.61, SE = 0.28, 95% CI: -1.28, -0.17), depressive symptoms (indirect effect, B = -0.50, SE = 0.21, 95% CI: -0.97, -0.15), and QOL (indirect effect, B = 3.80, SE = 1.25, 95% CI: 1.54, 6.49), but not symptom distress. Changes in self-efficacy did not mediate improvements in any of the proposed outcomes.</p><p><strong>Conclusion: </strong>Coping is an essential component of a brief group psychosocial intervention that drives improvements in mood and QOL for women with non-metastatic hormone receptor-positive breast cancer taking AET.</p><p><strong>Clinical trial registration: </strong>NCT03837496.</p>","PeriodicalId":20779,"journal":{"name":"Psycho‐Oncology","volume":"33 12","pages":"e70049"},"PeriodicalIF":3.3,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11936010/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142872794","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}